Diabetes risk scores and death: predictability and practicability in two different populations
|
|
- Jessie Jennings
- 6 years ago
- Views:
Transcription
1 Diabetes risk scores and death: predictability and practicability in two different populations Short Report David Faeh, MD, MPH 1 ; Pedro Marques-Vidal, MD, PhD 2 ; Michael Brändle, MD 3 ; Julia Braun, PhD 1 ; Sabine Rohrmann, PhD 1 1 Unit of Demography and Health Statistics and Division of Cancer Epidemiology and Prevention, Institute of Social and Preventive Medicine, University of Zurich, Zurich, Switzerland 2 Institute of Social and Preventive Medicine (IUMSP), anne University Hospital, anne, Switzerland 3 Division of Endocrinology and Diabetes, Kantonsspital St. Gallen, St. Gallen, Switzerland Correspondence: David Faeh, Institute of Social and Preventive Medicine (ISPM) University of Zurich Hirschengraben Zurich, Switzerland Tel.: Fax.: Mail: david.faeh@uzh.ch 1
2 Abstract The aim was to examine the capacity of commonly used type two diabetes mellitus (T2DM) risk scores to predict overall mortality. The US-based (n=3138; 982 deaths) and the Swiss-based Co study (n=3946; 191 deaths) were used. The predictive value of eight T2DM risk scores regarding overall mortality was tested. The Griffin score, based on few, self-reported parameters, presented the best ( ) and second best (Co) predictive capacity. Generally, the predictive capacity of scores based on clinical (anthropometrics, lifestyle, history) and biological (blood parameters) data was not better than of scores based solely on clinical, self-reported data. T2DM scores can be validly used to predict mortality risk in general populations without diabetes. Comparison with other scores could further show whether such scores also suit as a screening tool for quick overall health risk assessment. Key words diabetes; risk scores; risk prediction; mortality 2
3 Introduction Several scores have been proposed to identify persons at risk for type two diabetes mellitus (T2DM) 1-3. Many variables used in T2DM risk scores are common health risk factors, e.g. smoking, hypertension and (central) obesity. Hence, T2DM risk scores could possibly also serve to predict disease and death independently from T2DM. However, to date, only one score has been examined for this ability 4. The advantage of these scores over other risk scores (e.g. cardiovascular risk scores) is that most T2DM risk scores do not require blood sampling to obtain biological parameters (e.g. blood lipids). Thus, T2DM risk scores could be used for a general health risk assessment, potentially leading to lifestyle interventions. A comparison of different T2DM risk scores could show which score best meets this requirement. In this study, we assessed the predictive capacity of eight T2DM risk scores regarding overall mortality. Because there may be substantial variation in the predictive performance of the scores according to the population 3, one European and one US population-based sample was used. Methods Data from two population-based prospective studies was used. The US was conducted in and had mortality follow-up until December ; for this study, only data from non-hispanic white participants with fasting blood glucose <7 mmol/l and without T2DM was used (n=3138; 982 deaths). The Swiss Co study was conducted in and had mortality follow-up until September ; for this study, only data from participants without T2DM was used (n=3946; 191 deaths). Eight T2DM risk scores relying on self-reported information on anthropometrics, lifestyle or medical history (clinical) or on a combination of clinical factors and blood parameters (biological) were used: Balkau, Wilson, Griffin, Kahn (clinical and clinical+biological), FINDRISK, the Swiss and the German Diabetes Risk Score (GDRS) 1,3,4,7. Participants with missing information in any of the scores were excluded. The GDRS could only be calculated using the data, because no information on dietary habits is available in Co. For each score, a continuous (score) and a binary (risk yes/no) variable were computed. The predictive capacity regarding death from all causes was assessed using Harrell s C 8 and Area-under-the-curve (AUC) for the continuous variable. For the binary variable, we used sensitivity, specificity, positive and negative predictive values (PPV and NPV). No adjustment was made for age or sex as these variables were part of some scores. The predictive capacity of three individual biological parameters was also assessed: fasting blood glucose, glycated hemoglobin (HbA 1 c) and insulin resistance (HOMA-IR). Results The populations used to develop the T2DM scores and the variables the scores are composed of are shown in Tables A1 and A2 in the supplementary file. In, the percentage of participants for whom the score was not assessable due to missing information varied from 0% (Griffin) to 17% (Kahn s clinical + biological), whereas no participant from Co had missing information. The prevalence of participants at risk of T2DM varied between scores and, to a smaller extent, between surveys. In, the Griffin score presented the best predictive capacity, as shown by the largest Harrell s C, AUC (continuous variable), PPV and NPV (binary variable). In Co, Kahn s clinical score had the best predictive capacity, but the Griffin score ranked second best. Wilson, Balkau, Findrisc and SDRS had a high specificity but a very poor sensitivity (binary), thus being inappropriate for the prediction of death. The Griffin score offered the best combination of a high specificity and an acceptable sensitivity. In both surveys, the predictive capacity of scores based on clinical and biological data was not better than of scores based solely on clinical data (Table). Among individual biological parameters, HbA 1 c had the best predictive capacity in, while insulin resistance (HOMA-IR) had the lowest predictive capacity in both studies (Table). Discussion We examined whether T2DM risk scores could be envisaged as screening tool for overall health risk assessment and used all-cause mortality as outcome proxy. The capacity of T2DM scores to predict mortality differed considerably within a study population. However, the scores also performed differently in the two studies. The scores also varied regarding the number and the type of required variables, which was reflected in a broad range of the percentage of participants excluded because of missing values. Looking at both studies, the Griffin score generally had the best predictive capacity. Further, as it does not require blood sampling, the Griffin score is less costly and could be used for self-assessment by internet or paper questionnaire. Moreover, the applicability of this score appeared quite universal, since it performed similarly well in a European and in a US population. Still, the number of participants classified as being at risk using the Griffin score was high. This may be problematic because monitoring, coaching and treating a potentially large number of individuals at risk could be expensive and logistically demanding. It would be preferable to have a score with similar sensitivity/specificity values but leading to a lower prevalence of individuals at risk. In all scores and both study population samples, the sensitivity was relatively low. One reason for this may be that these scores were not developed to predict death as outcome and/or that the cutoff point should be adapted. Low sensitivity is problematic because a substantial proportion of persons who will die in the future are 3
4 missed. Interestingly, and in agreement with the literature 2, scores including biological data were not better than scores based solely on clinical data. This finding suggests that the inclusion of biological variables might not improve the predictive capacity of T2DM risk scores regarding overall mortality. Further studies are needed to better assess whether biological variables could be replaced by more easily obtainable parameters, e.g. also in scores predicting a cardiovascular outcome. HbA 1c had a good predictive capacity and led to a relatively low prevalence of participants at risk. Hence, HbA 1c could be used as a risk factor for overall mortality. In fact, HbA 1c performed significantly better than the lipid parameters traditionally used in models predicting cardiovascular disease mortality 9. HbA 1 c can also be measured and interpreted in the non-fasting state 10, thus facilitating screening procedures. We conclude that T2DM risk scores might be useful to predict the risk of death as a proxy for overall health risk. In both populations, scores based solely on clinical data were as efficient as scores additionally including biological variables. This could open door for the development of simple, self-administrable screening questionnaires allowing to assess and approach lifestyle factors. Acknowledgment This work was supported by the Swiss National Science Foundation (grants 3347CO , 33CS , 32473B ). The Colaus study was supported by grants from the Swiss National Science Foundation [grant no: 33CSCO and 3CSC ]; GlaxoSmithKline and the Faculty of Biology and Medicine of anne. Conflict of Interest None declared Key Points Numerous scores exist helping to identify persons at risk for type two diabetes mellitus The capacity of these scores to predict all-cause mortality and the usefulness in clinical practice has not been examined previously There were large differences regarding the prevalence of persons defined at risk and concerning the predictive capacity of the scores Scores based on solely clinical data may perform better than scores relying on clinical plus biological data This could open door for the development of simple, self-administrable screening questionnaires allowing to assess and approach lifestyle factors. References 1. Schmid R, Vollenweider P, Bastardot F, Waeber G, Marques-Vidal P. Validation of 7 type 2 diabetes mellitus risk scores in a population-based cohort: Co study. Arch Intern Med 2012;172: Noble D, Mathur R, Dent T, Meads C, Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. Bmj 2011;343:d Schmid R, Vollenweider P, Waeber G, Marques-Vidal P. Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the Cohorte annoise study. Diabetes Care 2011;34: Heidemann C, Boeing H, Pischon T, Nothlings U, Joost HG, Schulze MB. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol 2009;24: National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, Series 1: programs and collection procedures. Vital Health Stat : Firmann M, Mayor V, Vidal PM, et al. The Co study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008;8:6. 7. Schulze MB, Hoffmann K, Boeing H, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007;30: Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004;23: Faeh D, Rohrmann S, Braun J. Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts. Eur J Epidemiol 2013;28: Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:
5 Table. Characteristics of selected type 2 diabetes risk scores and single biological markers predicting all-cause mortality in two different surveys Assessment Continuous variable Binary variable Prevalence (%)* Missing (%)** Harrell's C AUC Sensitivity (%) Specificity (%) PPV (%) NPV (%) Predictor Type Items (n) Risk scores Wilson CB Balkau C Kahn 1 CB Kahn 2 C SDRS C GDRS** C Findrisc C Griffin C Single biological markers HOMA-IR 2.5 B FBG 6.1 mmol/l B HbA 1 c 5.9%** B : not assessed in the Co Study. *of persons at risk of type 2 diabetes; **only available for ; The scores were calculated based on a sample excluding participants with missing information for any of the scores, i.e. 17% AUC; area under the receiver operating curve; PPV, positive predictive value; NP, negative predictive value; Co, Cohorte annoise;, third National Health and Nutrition Examination Survey; C, clinical; CB; clinical + biological; B, biological; SDRS, Swiss Diabetes Risk Score from the Swiss Diabetes Association; GDRS, German Diabetes Risk Score from the EPIC-Potsdam cohort; HOMA-IR, Homeostasis Model Assessment of insulin resistance, defined as fasting insulin (mu/l) x fasting blood glucose (mmol/l) / 22,5; FBG, fasting blood glucose; HbA 1 c, glycated hemoglobin. 5
6 Supplementary File Table A1 Variables used for the generation of the diabetes risk scores Wilson Balkau (C) Kahn (C) SDRS GDRS Kahn (CB) FINDRISC Griffin Age Sex Genetics Familial history * Personal history Black race Lifestyle Smoking Alcohol Diet Physical activity Anthropometry BMI Weight Height Waist circumference Cardiovascular risk factors Resting pulse Hypertension HDL-Cholesterol Triglycerides Other Fasting glucose Prescribed Steroids Uric acid Number of variables * women only men only C : clinical, CB : clinical and biological (only specified in case of various equations provided by the authors); SDRS, Swiss Diabetes Risk Score from the Swiss Diabetes Association; GDRS, German Diabetes Risk Score 6
7 Table A2 Populations used and characteristics of the diabetes risk scores Wilson Balkau (C) Kahn (C) SDRS GDRS Kahn (CB) FINDRISC Griffin Study Framingham DESIR ARIC FINRISK EPIC ARIC FINRISK Ely and Wessex Study Country USA France USA Finland Germany USA Finland England Number of patients 3,140 3,817 12,729 4,435 27,548 12,729 4,435 1,077 Patients age (years) * 54.0 (9.8) Follow-up (years) Threshold to define high risk 33% 30% 33% 15 points 500 points 46% 12 points 37% AROC * mean (SD) or range cross sectional study men women AROC : Area Under the ROC Curve; C : clinical, CB : clinical and biological (only specified in case of various equations provided by the authors); SDRS, Swiss Diabetes Risk Score from the Swiss Diabetes Association; GDRS, German Diabetes Risk Score 7
Genetic Risk Score vs Other Predictors for Type 2 Diabetes
Genetic Risk Score vs Other Predictors for Type 2 Diabetes Vincent Mooser MD Expert Forum on Diabetes Rueschlikon, October 10th, 2017 Risk prediction for T2DM : Why we shall bother 1. High prevalence in
More informationImplementing Type 2 Diabetes Prevention Programmes
Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected
More informationWeb Extra material. Comparison of non-laboratory-based risk scores for predicting the occurrence of type 2
Web Extra material Comparison of non-laboratory-based risk scores for predicting the occurrence of type 2 diabetes in the general population: the EPIC-InterAct Study Outline Supplementary Figures Legend...
More informationDiagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children
Diagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children Adegboye ARA; Andersen LB; Froberg K; Heitmann BL Postdoctoral researcher, Copenhagen, Denmark Research
More informationWAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS?
WAIST-HEIGHT RATIO : A NEW OBESITY INDEX FOR FILIPINOS? Consuelo L. Orense, MSPH, Charmaine A. Duante, RMT, MS Epid.(PH), Ermelita N. Bautista, MPH and Lilibeth P. Dasco, MSAN ABSTRACT The study aimed
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationPREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS
PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS Mehmet Emre Atabek,MD,PhD Necmettin Erbakan University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology and
More informationSCIENTIFIC STUDY REPORT
PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationSection: Laboratory Last Reviewed Date: April Policy No: 66 Effective Date: July 1, 2014
Medical Policy Manual Topic: Multianalyte Assays with Algorithmic Analyses for Predicting Risk of Type 2 Diabetes Date of Origin: April 2013 Section: Laboratory Last Reviewed Date: April 2014 Policy No:
More informationAUTONOMIC FUNCTION IS A HIGH PRIORITY
AUTONOMIC FUNCTION IS A HIGH PRIORITY 1 Bladder-Bowel-AD Tetraplegia Sexual function Walking Bladder-Bowel-AD Paraplegia Sexual function Walking 0 10 20 30 40 50 Percentage of respondents an ailment not
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationPhysical activity as an aid for smoking cessation
Physical activity as an aid for smoking cessation - study David Faeh, MD Christiane Ruffieux, PhD Jacques Cornuz, MD, MPH Background Prevalence of smoking in Switzerland: 33% Most smokers cumulate both
More informationInitiating Insulin in Primary Care for Type 2 Diabetes Mellitus. Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre
Initiating Insulin in Primary Care for Type 2 Diabetes Mellitus Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre Outline How big is the problem? Natural progression of type 2 diabetes What
More informationGuidelines on cardiovascular risk assessment and management
European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine
More informationPrediction models in nutritional epidemiology
Science & Research Original Contribution Author's copy! Any use beyond the limits of copyright law without the consent of the publisher is prohibited and punishable. This applies in particular to duplications,
More informationN Follow -up years. (cases/controls or participants, gender) Cases: 105 men and 125 women; Controls: 206 men and 246 women
Supplementary Table 1. characteristics of 21 independent studies (extracted from 1 eligible articles) of blood 2(OH)D Levels and incident type 2 Author, Publicatio n year Source populatio n Design N Follow
More informationAmerican Academy of Insurance Medicine
American Academy of Insurance Medicine October 2012 Dr. Alison Moy Liberty Mutual Dr. John Kirkpatrick Thrivent Financial for Lutherans 1 59 year old male, diagnosed with T2DM six months ago Nonsmoker
More informationESPEN Congress Florence 2008
ESPEN Congress Florence 2008 Severe obesity - Session organised in conjunction with ASPEN The SOS study Setting the Scene A. Thorell (Sweden) The SOS study Setting the Scene Anders Thorell MD, PhD Associate
More informationModelling Reduction of Coronary Heart Disease Risk among people with Diabetes
Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made
More information300 Biomed Environ Sci, 2018; 31(4):
300 Biomed Environ Sci, 2018; 31(4): 300-305 Letter to the Editor Combined Influence of Insulin Resistance and Inflammatory Biomarkers on Type 2 Diabetes: A Population-based Prospective Cohort Study of
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationIschemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010
Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationORIGINAL INVESTIGATION. Prediction of Incident Diabetes Mellitus in Middle-aged Adults
ORIGINAL INVESTIGATION Prediction of Incident Diabetes Mellitus in Middle-aged Adults The Framingham Offspring Study Peter W. F. Wilson, MD; James B. Meigs, MD, MPH; Lisa Sullivan, PhD; Caroline S. Fox,
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationStatistical Fact Sheet Populations
Statistical Fact Sheet Populations At-a-Glance Summary Tables Men and Cardiovascular Diseases Mexican- American Males Diseases and Risk Factors Total Population Total Males White Males Black Males Total
More informationDirector, Employee Health & Productivity. Coordinator, Employee Health & Productivity
Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol
More informationTechnical Information Guide
Technical Information Guide This Guide provides information relating to the selection, utilization, and interpretation of the Quantose IR test. Information provided is based on peer-reviewed publications
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationPhysical health assessment and monitoring in long-term mental health care
Physical health assessment and monitoring in long-term mental health care Dr Alan Farmer Consultant Psychiatrist Worcestershire Mental Health Partnership NHS Trust A brief questionnaire Current thoughts,
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationAgreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions
DOI 10.1007/s10557-009-6162-y Agreement of Swiss-Adapted International and European Guidelines for the Assessment of Global Vascular Risk and for Lipid Lowering Interventions Michel Romanens & Franz Ackermann
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Solomon SD, Uno H, Lewis EF, et al. Erythropoietic response
More informationNHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Produced by: National Cardiovascular Intelligence Network (NCVIN)
NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia Produced by: National Cardiovascular Intelligence Network (NCVIN) Date: August 2015 About Public Health England Public Health England
More information290 Biomed Environ Sci, 2016; 29(4):
290 Biomed Environ Sci, 2016; 29(4): 290-294 Letter to the Editor Prevalence and Predictors of Hypertension in the Labor Force Population in China: Results from a Cross-sectional Survey in Xinjiang Uygur
More informationAssociation of hypothyroidism with metabolic syndrome - A case- control study
Article ID: ISSN 2046-1690 Association of hypothyroidism with metabolic syndrome - A case- control study Peer review status: No Corresponding Author: Dr. Veena K Karanth, Associate Professor, Surgery,
More informationClinical Recommendations: Patients with Periodontitis
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationSupplementary Online Content
Supplementary Online Content Kavousi M, Leening MJG, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines
More informationInsulin Resistance and Long-Term Cancer-Specific and All-Cause Mortality: The Women s Health Initiative (WHI)
Insulin Resistance and Long-Term Cancer-Specific and All-Cause Mortality: The Women s Health Initiative (WHI) May 3, 2018 Kathy Pan, Rebecca Nelson, Jean Wactawski-Wende, Delphine J. Lee, JoAnn E. Manson,
More informationOther Ways to Achieve Metabolic Control
Other Ways to Achieve Metabolic Control Nestor de la Cruz- Muñoz, MD, FACS Associate Professor of Clinical Surgery Chief, Division of Laparoendoscopic and Bariatric Surgery DeWitt Daughtry Family Department
More informationAppendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors.
Appendix This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Appendix to: Banks E, Crouch SR, Korda RJ, et al. Absolute risk of cardiovascular
More informationNon-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus
Diabetologia (2011) 54:73 77 DOI 10.1007/s00125-010-1945-z SHORT COMMUNICATION Non-fasting lipids and risk of cardiovascular disease in patients with diabetes mellitus S. van Dieren & U. Nöthlings & Y.
More informationFructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism
Fructose in diabetes: Friend or Foe Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism Contents What is Fructose? Why is Fructose of Concern? Effects of Fructose on glycemic
More informationPredicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome
https://doi.org/10.1186/s13098-018-0310-0 Diabetology & Metabolic Syndrome RESEARCH Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome Abraham S. Meijnikman
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More informationEXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT Submitted to UNIVERSITY GRANTS COMMISSION
1 A STUDY ON THE EFFECT OF DIET & LIFE STYLE ON THE INCIDENCE OF CORONARY ARTERY DISEASE IN MODERATELY DRINKING EX MILITARY MEN IN PATHANAMTHITTA DISTRICT. EXECUTIVE SUMMARY OF THE MINOR RESEARCH PROJECT
More informationGlycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults
The new england journal of medicine original article Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults Elizabeth Selvin, Ph.D., M.P.H., Michael W. Steffes, M.D., Ph.D., Hong
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationLifestyle Health Assessment.
Lifestyle Health Assessment. Nuffield Health. Specialists in you. Open the conversation. At Nuffield Health all our health assessments focus on preventative health. This means that we concentrate on informing
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationBariatric Surgery versus Intensive Medical Therapy for Diabetes 3-Year Outcomes
The new england journal of medicine original article Bariatric Surgery versus Intensive Medical for Diabetes 3-Year Outcomes Philip R. Schauer, M.D., Deepak L. Bhatt, M.D., M.P.H., John P. Kirwan, Ph.D.,
More informationChronic Benefit Application Form Cardiovascular Disease and Diabetes
Chronic Benefit Application Form Cardiovascular Disease and Diabetes 19 West Street, Houghton, South Africa, 2198 Postnet Suite 411, Private Bag X1, Melrose Arch, 2076 Tel: +27 (11) 715 3000 Fax: +27 (11)
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More informationThe Importance of Local Research in Developing Health Strategy The Case of Cardiovascular Disease Prevention in Sri Lanka
The Importance of Local Research in Developing Health Strategy The Case of Cardiovascular Disease Prevention in Sri Lanka Dr Ravi P. Rannan-Eliya, Dr Nilmini Wijemanne Institute for Health Policy KDU International
More informationMississippi Stroke Systems of Care
Stroke Initiatives Mississippi State Department of Health Cassandra Dove, Chronic Disease Bureau 19 th Annual Stroke Belt Consortium March 1, 2014 Mississippi Stroke Systems of Care Heart Disease and Stroke
More informationARTICLE. Y. Heianza & Y. Arase & S. D. Hsieh & K. Saito & H. Tsuji & S. Kodama & S. Tanaka & Y. Ohashi & H. Shimano & N. Yamada & S. Hara & H.
Diabetologia (2012) 55:3213 3223 DOI 10.1007/s00125-012-2712-0 ARTICLE Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationA simple screening score for diabetes for the Korean population
2012 International Conference on Diabetes and Metabolism S7. Epidemiologic issues on diabetes Friday 9 November, 2012 A simple screening score for diabetes for the Korean population Dae Jung Kim, MD Associate
More informationSUPPLEMENTAL MATERIAL. Materials and Methods. Study design
SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationMETABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS
Rev. Med. Chir. Soc. Med. Nat., Iaşi 2012 vol. 116, no. 4 INTERNAL MEDICINE - PEDIATRICS ORIGINAL PAPERS METABOLIC SYNDROME IN OBESE CHILDREN AND ADOLESCENTS Ana-Maria Pelin 1, Silvia Mǎtǎsaru 2 University
More informationAssessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and women
Diabetologia (2010) 53:890 898 DOI 10.1007/s00125-010-1670-7 ARTICLE Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6,923 older men and
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationEnergy Balance Equation
Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationExercise Studies Where Walking is Better than Running: Does Intensity Matter?
Exercise Studies Where Walking is Better than Running: Does Intensity Matter? Frontiers in Medicine The Forest 24 September 2018 William E. Kraus, M.D. Exercise Intensity and Volume Effects: Confounded?
More informationAlthough the prevalence and incidence of type 2 diabetes mellitus
n clinical n Validating the Framingham Offspring Study Equations for Predicting Incident Diabetes Mellitus Gregory A. Nichols, PhD; and Jonathan B. Brown, PhD, MPP Background: Investigators from the Framingham
More informationPatient: Shawn Baker March 06, 2018
Mr. Shawn Baker Dear Participant: Our team at SpecialtyHealth has received your lab work and the results have been reviewed. In this letter you will find a summary of the results along with numerous charts
More informationPlasma concentrations of afamin are associated with the metabolic syndrome and related diseases
Plasma concentrations of afamin are associated with the metabolic syndrome and related diseases Hans Dieplinger Division of Genetic Epidemiology Medical University of Innsbruck, Austria 6 th Munich Biomarker
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationA: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups
A: Epidemiology update Evidence that LDL-C and CRP identify different high-risk groups Women (n = 27,939; mean age 54.7 years) who were free of symptomatic cardiovascular (CV) disease at baseline were
More informationWhat s new in cardiovascular disease risk assessment and management for primary care clinicians
Cardiovascular system What s new in cardiovascular disease risk assessment and management for primary care clinicians The recently released 2018 Cardiovascular Disease Risk Assessment and Management for
More informationThe Diabetes Link to Heart Disease
The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM
More informationGlucose Challenge Test as a Predictor of Type 2 Diabetes
Georgia State University ScholarWorks @ Georgia State University Public Health Theses School of Public Health Fall 1-8-2016 Glucose Challenge Test as a Predictor of Type 2 Diabetes Rahsaan Overton Follow
More informationPhysical Activity, Sedentary Behaviors and the Incidence of Type 2 Diabetes Mellitus: The Multi-
Physical Activity, Sedentary Behaviors and the Incidence of Type 2 Diabetes Mellitus: The Multi- Ethnic Study of Atherosclerosis (MESA) Running Title: Physical Activity, Sedentary Behavior and Incident
More informationMortality from coronary heart disease (CHD), cardiovascular
Epidemiology Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults Shaista Malik, MD, MPH; Nathan D. Wong, PhD, MPH;
More informationSupplementary Online Content
Supplementary Online Content Anagnostou E, Aman MG, Handen BL, et al. Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autistic spectrum disorder:
More informationHealth benefits of mango supplementation as it relates to weight loss, body composition, and inflammation: a pilot study
Title of Study: Health benefits of mango supplementation as it relates to weight loss, body composition, and inflammation: a pilot study Principal Investigator: Dr. Edralin A. Lucas Nutritional Sciences
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationELEVATED 1 HOUR GLUCOSE DURING ORAL GLUCOSE TOLERANCE TEST- A NEW PARAMETER OF IMPAIRED METABOLISM
2016 ILEX PUBLISHING HOUSE, Bucharest, Roumania http://www.jrdiabet.ro Rom J Diabetes Nutr Metab Dis. 23(3):267-275 doi: 10.1515/rjdnmd-2016-0031 ELEVATED 1 HOUR GLUCOSE DURING ORAL GLUCOSE TOLERANCE TEST-
More informationLifestyle, Biomarkers and Atherosclerosis the LBA study
Lifestyle, Biomarkers and Atherosclerosis the LBA study Ulrika Fernberg 2016-10-11 1 Aim of the LBA study The aim of the project is to assess vessel wall structure and function in a large cohort of young
More informationJournal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.
Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More informationPrevention of Cardiovasular Diseases
Role and Significance of In-Vitro-Diagnostics in the Healthcare Systems of the Future Prevention of Cardiovasular Diseases Michael Walter Charité University Medicine, Berlin & Unfallkrankenhaus Berlin
More informationTable S2: Anthropometric, clinical, cardiovascular and appetite outcome changes over 8 weeks (baseline-week 8) by snack group
Table S1: Nutrient composition of cracker and almond snacks Cracker* Almond** Weight, g 77.5 g (5 sheets) 56.7 g (2 oz.) Energy, kcal 338 364 Carbohydrate, g (kcal) 62.5 12.6 Dietary fiber, g 2.5 8.1 Protein,
More informationIndividual Study Table Referring to Item of the Submission: Volume: Page:
2.0 Synopsis Name of Company: Abbott Laboratories Name of Study Drug: Meridia Name of Active Ingredient: Sibutramine hydrochloride monohydrate Individual Study Table Referring to Item of the Submission:
More informationJohn J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam
Latest Insights from the JUPITER Study John J.P. Kastelein MD PhD Professor of Medicine Dept. of Vascular Medicine Academic Medial Center / University of Amsterdam Inflammation, hscrp, and Vascular Prevention
More informationClinical Therapeutics/Volume 33, Number 1, 2011
Clinical Therapeutics/Volume 33, Number 1, 2011 Concurrent Control of Blood Glucose, Body Mass, and Blood Pressure in Patients With Type 2 Diabetes: An Analysis of Data From Electronic Medical Records
More informationORIGINAL INVESTIGATION. Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer Norfolk Cohort
ORIGINAL INVESTIGATION Evaluation of the Framingham Risk Score in the European Prospective Investigation of Cancer Norfolk Cohort Does Adding Glycated Hemoglobin Improve the Prediction of Coronary Heart
More informationThe product of fasting plasma glucose and triglycerides improves risk prediction of type 2 diabetes in middle-aged Koreans
Lee et al. BMC Endocrine Disorders (2018) 18:33 https://doi.org/10.1186/s12902-018-0259-x RESEARCH ARTICLE Open Access The product of fasting plasma glucose and triglycerides improves risk prediction of
More informationText-based Document. Predicting Factors of Body Fat of Metabolic Syndrome Persons. Downloaded 13-May :51:47.
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More information